New Leadership Appointments for AI, Technology, and Data at HHS
January 14, 2025 - 12:37
In a significant move to enhance its technological capabilities, the Department of Health and Human Services (HHS) has appointed three key officials to oversee its artificial intelligence, technology, and data initiatives. This decision follows a major restructuring of the agency's technology and cybersecurity operations that took place in July.
The new appointments include a Chief Artificial Intelligence Officer (CAIO), a Chief Technology Officer (CTO), and a Chief Data Officer (CDO). These roles are designed to streamline HHS's approach to integrating advanced technologies and data management into its operations. By establishing dedicated leadership in these areas, HHS aims to improve its efficiency and effectiveness in delivering health services and responding to public health challenges.
The new officials are expected to drive innovation and ensure that the agency leverages cutting-edge technologies to enhance health outcomes. Their leadership will be crucial in navigating the complexities of data privacy and security while promoting the responsible use of AI in healthcare.
MORE NEWS
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...